The DNA Stutter: Understanding Huntington’s Disease and the Legacy of Nancy Wexler

 



Huntington’s Disease (HD) was once one of medicine’s darkest mysteries—a "family curse" that caused a slow, inevitable decline in movement, mind, and mood. For decades, families lived in fear, never knowing if they carried the fatal "stutter" in their DNA.
The reason we can now name that stutter—the CAG repeat—is largely thanks to the tireless work of Dr. Nancy Wexler.
The Stakes Were Personal
Nancy Wexler wasn't just a researcher; she was a daughter at risk. In 1968, her mother was diagnosed with Huntington’s Disease. Because the disease is autosomal dominant, Nancy and her sister each had a 50% chance of having inherited the same fate.
Rather than waiting for symptoms to appear, Wexler dedicated her life to finding the gene responsible.
The Lake Maracaibo Breakthrough
In 1979, Wexler led a research team to the shores of Lake Maracaibo in Venezuela. There, they found the world's largest extended family with Huntington's Disease—thousands of descendants of a single ancestor who lived in the early 1800s.
For over 20 years, Wexler and her team:
  • Collected blood samples and skin biopsies.
  • Mapped a genealogical tree of over 18,000 individuals.
  • Documented the progression of the disease with unprecedented detail.
Identifying the "Stutter" (1993)
This massive "family tree" allowed scientists to pinpoint the exact location of the gene on Chromosome 4. In 1993, the Huntingtin (HTT) gene was finally isolated.
The discovery revealed the "CXG" mechanism:
  • The Repeat: Every person has a section of DNA where the letters C-A-G repeat.
  • The Threshold: If you have 36 or more repeats, the resulting protein becomes toxic, eventually killing neurons in the brain’s striatum.
The Double-Edged Sword of Discovery
Wexler’s work led to the first-ever pre-symptomatic genetic test for a neurological disease. However, this created a profound ethical dilemma: If there is no cure, would you want to know your fate?
For 27 years, Wexler kept her own genetic status private, advocating for the "right not to know" and focusing on the ethics of genetic testing. In 2020, at the age of 74, she publicly revealed that she, too, had inherited the gene and was symptomatic, continuing her advocacy from a position of immense personal bravery.
Why Her Legacy Matters Today
Because of Nancy Wexler, we have moved from "searching for a ghost" to "targeting a protein." Today’s most promising treatments, such as antisense oligonucleotides (ASOs), aim to "silence" the toxic gene expansion—a therapy that would be impossible without the map she created in Venezuela.

Comments

Post a Comment

Popular posts from this blog

The Universe's Blueprint — And What It Teaches Us

  The Universe's  Blueprint — And What It Teaches Us Astronomers just found that the Milky Way floats inside a vast dark-matter sheet squeezed between two cosmic voids. But here's the stranger idea: that same sheet-and-void pattern shows up in your brain, your lungs, a soap bubble, and possibly the future of AI computation. Nature has one favourite shape — and it's been hiding it everywhere. Based on:  Wempe, Helmi et al. — Nature Astronomy, Jan 2026 Extended analysis:  Applications · Nature · AI March 2026 The Groningen team's discovery — that the Milky Way is embedded in a flat sheet of dark matter flanked by near-empty cosmic voids — solved a nearly century-old puzzle in astronomy. But buried inside that solution is something even more arresting: a structural principle.  Sheet-plus-void  is not an accident of our particular corner of the universe. It is what gravity does to matter, given enough time and space. And gravity is not alone. Surface tension, n...
Read more

Gene Series - Part 2 : DMD & Duchenne Muscular Dystrophy

  The Gene Files · Series 1 · Blog 2 The Largest Gene, the Heaviest Burden: DMD & Duchenne Muscular Dystrophy The biggest gene in the human genome, 2.4 megabases long and taking 16 hours to transcribe — and why the absence of its 427-kDa protein product makes muscles self-destruct Gene:  DMD (Dystrophin) Chromosome:  Xp21.2 Protein:  Dystrophin — 3,685 aa, 427 kDa Disease:  Duchenne Muscular Dystrophy Gene identified:  1986 Protein named:  1987 On a December night in 1987, a young postdoctoral researcher named Eric Hoffman stayed late in Louis Kunkel's lab at Harvard Medical School, running a Western blot on a muscle biopsy from a patient with Duchenne muscular dystrophy. When the blot developed, the result was unambiguous: the band representing the protein — the one they had just predicted from the gene sequence but had never seen in a human sample — was completely absent from the DMD patient's muscle. Present in the normal control. Absent in DMD....
Read more

Einstein vs Bohr · The Great Quantum Debate · 10-Part Series : Part 1

  Einstein vs Bohr · The Great Quantum Debate · 10-Part Series I The Two Minds Before the arguments began — who were these men, what did they believe, and what divided them at the deepest level? PERIOD: 1879–1927 SETTING: Pre-debate context KEY THEME: Two philosophies of physics The greatest intellectual debate in the history of science did not begin with a paper. It began with a conversation — in a dining hall, between dinner courses, in the Hotel Métropole in Brussels in October 1927, with one man drawing on a napkin while the other paced the floor. But to understand why that argument shook the foundations of physics for the next three decades, and why it still matters today, we must go back much further — to the childhoods and educations of two men who had arrived at the same frontier of knowledge from entirely opposite directions. Albert Einstein  and  Niels Bohr  were, in almost every respect, complementary opposites. Einstein was born in Ulm, Germany; Bohr in C...
Read more